Company profile CYCN
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Cyclerion Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 143 | 108 -24.5% QoQ | 154 42.6% QoQ | 407 164.3% QoQ |
| 2020 | 247 72.7% YoY -39.3% QoQ | 184 70.4% YoY -25.5% QoQ | 218 41.6% YoY 18.5% QoQ | 111 -72.7% YoY -49.1% QoQ |
| 2021 | 90 -63.6% YoY -18.9% QoQ | 87 -52.7% YoY -3.3% QoQ | 54 -75.2% YoY -37.9% QoQ | 89 -19.8% YoY 64.8% QoQ |
| 2022 | 109 21.1% YoY 22.5% QoQ | 60 -31.0% YoY -45.0% QoQ | 64 18.5% YoY 6.7% QoQ | 87 -2.2% YoY 35.9% QoQ |
| 2023 | 105 -3.7% YoY 20.7% QoQ | 65 8.3% YoY -38.1% QoQ | 143 123.4% YoY 120.0% QoQ | 44 -49.4% YoY -69.2% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Cyclerion Therapeutics was 9.84 per week. The last year interest of Cyclerion Therapeutics compared to the last 5 years has changed by -41.57%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -68.16%.
After 34 days of this quarter the interest is at 26.0. Based on that we can calculate that during remaining 58 days it will total up to 70.0. Cyclerion Therapeutics stock expected interest is significantly higher compared to same quarter last year (+inf%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 133 |
| 2019 | 103 -22.6% QoQ | 62 -39.8% QoQ | 186 200.0% QoQ | 151 13.5% YoY -18.8% QoQ |
| 2020 | 112 8.7% YoY -25.8% QoQ | 110 77.4% YoY -1.8% QoQ | 67 -64.0% YoY -39.1% QoQ | 86 -43.0% YoY 28.4% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 322 192.7% YoY inf% QoQ | 73 9.0% YoY -77.3% QoQ | 242 181.4% YoY 231.5% QoQ |
| 2022 | 161 inf% YoY -33.5% QoQ | 126 -60.9% YoY -21.7% QoQ | 135 84.9% YoY 7.1% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 44 -72.7% YoY inf% QoQ | 38 -69.8% YoY -13.6% QoQ | 111 -17.8% YoY 192.1% QoQ | 26 inf% YoY -76.6% QoQ |
The average 5 years interest of Cyclerion Therapeutics stock was 8.8 per week. The last year interest of Cyclerion Therapeutics stock compared to the last 5 years has changed by -52.16%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -61.73%.
There is not enough data for Zagociguat to provide analysis
There is not enough data for Zagociguat to provide correlation calculation
There is not enough data for Zagociguat to provide analysis
After 34 days of this quarter the interest is at 159.0. Based on that we can calculate that during remaining 58 days it will total up to 430.0. Alzheimer's disease treatment expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+inf%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 177 |
| 2019 | 176 -0.6% QoQ | 151 -14.2% QoQ | 237 57.0% QoQ | 286 61.6% YoY 20.7% QoQ |
| 2020 | 277 57.4% YoY -3.1% QoQ | 184 21.9% YoY -33.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 159 inf% YoY inf% QoQ |
The average 5 years interest of Alzheimer's disease treatment was 6.31 per week. The last year interest of Alzheimer's disease treatment compared to the last 5 years has changed by -51.51%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -80.88%.
There is not enough data for Praliciguat clinical trials to provide analysis
There is not enough data for Praliciguat clinical trials to provide correlation calculation
There is not enough data for Praliciguat clinical trials to provide analysis
There is not enough data for Olinciguat sickle cell disease to provide analysis
There is not enough data for Olinciguat sickle cell disease to provide correlation calculation
There is not enough data for Olinciguat sickle cell disease to provide analysis
There is not enough data for CY3018 neuropsychiatric diseases to provide analysis
There is not enough data for CY3018 neuropsychiatric diseases to provide correlation calculation
There is not enough data for CY3018 neuropsychiatric diseases to provide analysis
After 34 days of this quarter the interest is at 57.0. Based on that we can calculate that during remaining 58 days it will total up to 154.0. Cyclerion Therapeutics news expected interest is significantly higher compared to previous quarter (+266.7%) and same quarter last year (+85.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 44 |
| 2019 | 25 -43.2% QoQ | 106 324.0% QoQ | 101 -4.7% QoQ | 99 125.0% YoY -2.0% QoQ |
| 2020 | 72 188.0% YoY -27.3% QoQ | 38 -64.2% YoY -47.2% QoQ | 107 5.9% YoY 181.6% QoQ | 85 -14.1% YoY -20.6% QoQ |
| 2021 | 100 38.9% YoY 17.6% QoQ | 66 73.7% YoY -34.0% QoQ | 33 -69.2% YoY -50.0% QoQ | 50 -41.2% YoY 51.5% QoQ |
| 2022 | 48 -52.0% YoY -4.0% QoQ | 75 13.6% YoY 56.2% QoQ | 162 390.9% YoY 116.0% QoQ | 83 66.0% YoY -48.8% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 60 -20.0% YoY inf% QoQ | 42 -74.1% YoY -30.0% QoQ | 57 -31.3% YoY 35.7% QoQ |
The average 5 years interest of Cyclerion Therapeutics news was 5.59 per week. The last year interest of Cyclerion Therapeutics news compared to the last 5 years has changed by -27.73%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -28.75%.
After 34 days of this quarter the interest is at 250.0. Based on that we can calculate that during remaining 58 days it will total up to 676.0. Biotechnology industry expected interest is significantly higher compared to previous quarter (+97.7%) and same quarter last year (+72.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 155 |
| 2019 | 533 243.9% QoQ | 500 -6.2% QoQ | 317 -36.6% QoQ | 377 143.2% YoY 18.9% QoQ |
| 2020 | 496 -6.9% YoY 31.6% QoQ | 352 -29.6% YoY -29.0% QoQ | 418 31.9% YoY 18.8% QoQ | 343 -9.0% YoY -17.9% QoQ |
| 2021 | 443 -10.7% YoY 29.2% QoQ | 460 30.7% YoY 3.8% QoQ | 315 -24.6% YoY -31.5% QoQ | 319 -7.0% YoY 1.3% QoQ |
| 2022 | 554 25.1% YoY 73.7% QoQ | 648 40.9% YoY 17.0% QoQ | 407 29.2% YoY -37.2% QoQ | 392 22.9% YoY -3.7% QoQ |
| 2023 | 638 15.2% YoY 62.8% QoQ | 478 -26.2% YoY -25.1% QoQ | 342 -16.0% YoY -28.5% QoQ | 250 -36.2% YoY -26.9% QoQ |
The average 5 years interest of Biotechnology industry was 33.6 per week. The last year interest of Biotechnology industry compared to the last 5 years has changed by 11.1%. The interest for Biotechnology industry is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 16.88%.
After 34 days of this quarter the interest is at 74.0. Based on that we can calculate that during remaining 58 days it will total up to 200.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 159 |
| 2019 | 299 88.1% QoQ | 316 5.7% QoQ | 197 -37.7% QoQ | 219 37.7% YoY 11.2% QoQ |
| 2020 | 698 133.4% YoY 218.7% QoQ | 561 77.5% YoY -19.6% QoQ | 345 75.1% YoY -38.5% QoQ | 355 62.1% YoY 2.9% QoQ |
| 2021 | 526 -24.6% YoY 48.2% QoQ | 307 -45.3% YoY -41.6% QoQ | 250 -27.5% YoY -18.6% QoQ | 264 -25.6% YoY 5.6% QoQ |
| 2022 | 286 -45.6% YoY 8.3% QoQ | 277 -9.8% YoY -3.1% QoQ | 275 10.0% YoY -0.7% QoQ | 309 17.0% YoY 12.4% QoQ |
| 2023 | 306 7.0% YoY -1.0% QoQ | 295 6.5% YoY -3.6% QoQ | 259 -5.8% YoY -12.2% QoQ | 74 -76.1% YoY -71.4% QoQ |
The average 5 years interest of Healthcare stocks was 25.3 per week. The last year interest of Healthcare stocks compared to the last 5 years has changed by -15.1%. The interest for Healthcare stocks is significantly decreasing. The last year interest is comparable to 5 years ago. It has changed only by 5.09%.